New monthly shot could simplify mental health treatment
NCT ID NCT07185815
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 24 times
Summary
This study tests a long-acting injection of cariprazine given once a month under the skin. It is for people with schizophrenia, bipolar I disorder, or major depressive disorder who are stable on other medications. The goal is to check safety, how the drug moves in the body, and if it helps control symptoms. About 24 participants will receive escalating doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mapi Pharma Investigational Site IL-001
RECRUITINGTel Aviv, 6423906, Israel
Contact
-
Mapi Pharma Investigational Site IL-003
RECRUITINGNess Ziona, 741000, Israel
Contact
-
Mapi Pharma Investigational Site IL-004
RECRUITINGBeersheba, 8461144, Israel
Contact
-
Mapi Pharma Investigational Site IL-005
RECRUITINGRamat Gan, 56621, Israel
Contact
-
Mapi Pharma Investigational Site IN-101
RECRUITINGAhmedabad, 380008, India
Contact
-
Mapi Pharma Investigational Site IN-102
RECRUITINGAhmedabad, 380016, India
Contact
Conditions
Explore the condition pages connected to this study.